EUVIMEDEUVIMED entdecken
Open Access

FDA-Regulated AI-Enabled Medical Devices With Pediatric Indications

Grzegorz Zapotoczny, Ansh Goyal, Madison Christmas, Shahida Qazi, Michael Carroll, Juan Espinoza

JAMA Network Open · 20.03.2026 · 9 (3) · e262636

DOI: 10.1001/jamanetworkopen.2026.2636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 20.03.2026. Verfasst von Grzegorz Zapotoczny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Artificial Intelligence, Device Approval, Equipment and Supplies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FDA HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Artificial intelligence (AI)–based technologies hold promise for faster and more accurate devices in health care; however, little is known about their availability to pediatric patients. A comprehensive analysis of US Food and Drug Administration (FDA) regulatory submissions is necessary to identify technologies with pediatric labeling.

Objective

To characterize AI devices marketed in the US, identify those with pediatric indications, and provide clues on AI-specific barriers to pediatric device innovation. Design, Setting, and Participants This retrospective descriptive cross-sectional study was conducted using public data from the FDA’s AI-Enabled Medical Device List. Marketing submissions reviewed by the FDA between November 1995 and June 2024 were analyzed. Main Outcomes and Measures Prevalence of pediatric AI devices and their main characteristics (eg, clinical area, review time, and year of FDA marketing decision).

Results

Among 952 submissions, 42 (4.4%) included pediatric age ranges (0-17 years). The first pediatric-inclusive device was cleared in 2015, and 5 exclusively pediatric technologies were introduced between 2020 and 2024. Of 18 clinical areas, radiology comprised 723 of all devices (75.9%) but only 18 of the devices specifically labeled for pediatrics (42.9%), whereas neurology comprised 34 devices overall (3.6%) vs 13 pediatric devices (31.0%); 10 clinical areas (55.6%) were missing among pediatric devices. The median (IQR) FDA review time was significantly longer for pediatric than for nonpediatric devices (162 [114-228] days; 95% CI, 151-212 days vs 134 [87-214] days; 95% CI, 149-162 days; 2-sided Mann-Whitney U test P = .049). Based on National Clinical Trial Identifiers in FDA summaries, clinical trial registration was noted in 6 pediatric (14.3%) vs 20 of 906 nonpediatric (2.2%) submissions. Conclusions and Relevance In this study, pediatric devices were rare, emerged recently, and had longer review times and a higher proportion of registered clinical trials compared with nonpediatric devices, suggesting expectations for more pediatric-specific evidence despite unchanged statutory standards. To address gaps in pediatric device development, the FDA should standardize age labeling and validation requirements for AI-enabled technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Food and Drug AdministrationArtificial IntelligenceDevice ApprovalEquipment and SuppliesPediatricsHumansUnited StatesCross-Sectional StudiesChildRetrospective StudiesChild, PreschoolInfantAdolescentInfant, NewbornFemaleMale

Autor:innen und Institutionen

  • Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora.

Förderung

  • FDA HHS

Zitieren

APA

Zapotoczny, G., Goyal, A., Christmas, M., Qazi, S., Carroll, M., & Espinoza, J. (2026). FDA-Regulated AI-Enabled Medical Devices With Pediatric Indications. JAMA Network Open, 9(3), e262636. https://doi.org/10.1001/jamanetworkopen.2026.2636

Vancouver

Zapotoczny G, Goyal A, Christmas M, Qazi S, Carroll M, Espinoza J. FDA-Regulated AI-Enabled Medical Devices With Pediatric Indications. JAMA Network Open. 2026;9(3):e262636. doi:10.1001/jamanetworkopen.2026.2636

BibTeX
@article{Zapotoczny2026,
  author = {Zapotoczny, Grzegorz and Goyal, Ansh and Christmas, Madison and Qazi, Shahida and Carroll, Michael and Espinoza, Juan},
  title = {FDA-Regulated AI-Enabled Medical Devices With Pediatric Indications},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {e262636},
  doi = {10.1001/jamanetworkopen.2026.2636}
}
Kostenlos starten →